Summary information and primary citation
- PDB-id
-
1d45;
DSSR-derived features in text and
JSON formats
- Class
- DNA
- Method
- X-ray (1.9 Å)
- Summary
- DNA dodecamer c-g-c-g-a-a-t-t-c-g-c-g-hoechst 33258
complex:-25 degrees c, piperazine down
- Reference
-
Quintana JR, Lipanov AA, Dickerson RE (1991): "Low-temperature
crystallographic analyses of the binding of Hoechst 33258
to the double-helical DNA dodecamer
C-G-C-G-A-A-T-T-C-G-C-G." Biochemistry,
30, 10294-10306. doi: 10.1021/bi00106a030.
- Abstract
- The crystal structure of the complex of Hoechst 33258
and the DNA dodecamer C-G-C-G-A-A-T-T-C-G-C-G has been
solved from X-ray data collected at three different low
temperatures (0, -25, and -100 degrees C). Such
temperatures have permitted collection of higher resolution
data (2.0, 1.9, and 2.0 A, respectively) than with previous
X-ray studies of the same complex. In all three cases, the
drug is located in the narrow central A-A-T-T region of the
minor groove. Data analyses at -25 and -100 degrees C (each
with a 1:1 drug/DNA ratio in the crystallizing solution)
suggest a unique orientation for the drug. In contrast, two
orientations of the drug were found equally possible at 0
degrees C with a 2:1 drug/DNA ratio in solution. Dihedral
angles between the rings of Hoechst 33258 appear to change
in a temperature-dependent manner. The drug/DNA complex is
stabilized by single or bifurcated hydrogen bonds between
the two N-H hydrogen-bond donors in the benzimidazole rings
of Hoechst and adenine N3 and thymine O2 acceptors in the
minor groove. A general preference for AT regions is
conferred by electrostatic potential and by narrowing of
the walls of the groove. Local point-by-point AT
specificity follows from close van der Waals contacts
between ring hydrogen atoms in Hoechst 33258 and the C2
hydrogens of adenines. Replacement of one benzimidazole
ring by purine in a longer chain analogue of Hoechst 33258
could make that particular site GC tolerant in the manner
observed at imidazole substitution for pyrrole in
lexitropsins.